The champagne was still flowing from our New Y()rk Stock Exchange celebration when the man who had promised to marry me handed thirty percent of our company’s shares to another woman. I stood there with prescription stomach medicine in my hand, watching Marcus smile at her the way he used to smile at me. Seven years of sleepless nights, hospital visits, and sacrifices had brought us to this moment, and somehow I had become the only person in the room who didn’t belong.
Chapter 2
The invitation to Aura’s global product launch arrived by email even though my employee credentials had already been revoked. Someone in public relations had apparently forgotten to remove me from the executive mailing list. I opened it while sitting in the conference room of Julian Thorne’s private investment firm, and for a moment I could hardly believe what I was reading.
Vivian Shaw was being presented as the sole creative force behind Aura’s newest fragrance.
The announcement included a photograph of her holding a leather-bound laboratory notebook.
My notebook.
I recognized the faded cover and the little scorch mark near its lower corner. Three years earlier, I’d accidentally knocked it against an alcohol burner after working nearly thirty hours without proper sleep. The mark had remained as a reminder to stop treating exhaustion like an accomplishment.
Now Vivian was holding it for publicity photographs.
Julian leaned over my shoulder.
“Is that yours?”
“Every page.”
“Then we’re going to have a very interesting conversation with their lawyers.”
Julian was forty-one, the quiet, observant heir to a family-owned luxury company with fragrance houses in Europe and distribution agreements throughout the United States. Unlike Marcus, he rarely raised his voice or made promises he couldn’t keep. He had approached me months earlier about establishing an independent perfume brand, but I’d refused because I still believed Marcus and I had a future.
Now Julian offered me a partnership with majority ownership and complete creative authority.
“Fifty-one percent belongs to you,” he told me. “The formulas remain yours. We provide capital, manufacturing support, and international distribution. Nobody gets to put another person’s name on your work.”
I studied the agreement carefully.
“And if we disagree?”
“Then we discuss it until we understand each other. I don’t expect you to agree simply because I wrote the check.”
It was such a reasonable answer that I nearly cried.
We signed the preliminary agreement that afternoon.
Our new company would be called Ward & Thorne.
Meanwhile, Aura’s launch preparations moved forward.
Marcus had arranged a lavish event at Lincoln Center, inviting investors, department-store buyers, fashion editors, and business reporters. A giant screen would display the company’s production plans, and a ceremonial button would signal the beginning of manufacturing at several facilities.
I watched the live broadcast from Julian’s conference room.
Marcus looked magnificent in a charcoal suit. His hair was perfectly styled, and he wore the confident smile that had once convinced investors to gamble their savings on our little basement business.
“Ladies and gentlemen,” he announced, “tonight Aura begins a bold new chapter under the creative leadership of Vivian Shaw.”
Vivian walked onto the stage wearing an ivory gown.
In her arms was my notebook.
“This journal represents years of research and countless sleepless nights,” she told the audience. “Every formula inside it reflects the dedication required to create something truly extraordinary.”
I gripped the edge of the table.
Julian quietly placed a glass of water beside me.
“Remember,” he said, “you don’t have to interrupt them. The documents will speak.”
A reporter stood during the questions.
“Mr. Foster, industry sources have long identified Elena Ward as Aura’s principal fragrance developer. Why isn’t she here tonight?”
Marcus smiled.
“Elena was an important member of our support team. She’s taking some well-deserved time away for health reasons.”
Support team.
I had developed the formulas, negotiated the manufacturing processes, and trained the laboratory employees.
Yet according to Marcus, I had merely supported Vivian.
Another reporter raised her hand.
“Public patent records identify Ms. Ward as the inventor of several formulations associated with tonight’s launch. Does Aura own those rights?”
Marcus gave a reassuring laugh.
“All necessary intellectual-property arrangements are in place. There’s no dispute.”
Julian looked toward our attorney, who was seated at the far end of the room.
She nodded.
“The emergency hearing was completed this afternoon. The court has ordered Aura to stop using the disputed formulations until ownership and licensing questions are resolved.”
I stared at the television.
Marcus continued speaking as though nothing could possibly go wrong.
The host announced the ceremonial start of production.
A countdown appeared on the screen.
Ten.
Nine.
Eight.
Marcus and Vivian stepped toward a bright red button.
Seven.
Six.
Suddenly, two men hurried onto the stage.
One was Aura’s general counsel. The other was the head of manufacturing.
They reached Marcus just before he touched the button.
“Stop,” the attorney whispered urgently. “You cannot authorize production.”
Marcus tried to smile for the cameras.
“What are you doing?”
“The court issued an order. The formulas aren’t cleared for commercial use.”
Vivian stared at the attorney.
“What?”
“Elena Ward’s company terminated the licenses, and the court has temporarily prohibited production pending further proceedings.”
Marcus’s smile disappeared.
For several seconds, no one moved.
Then the audience began whispering.
A reporter called out a question. Another stood to take a photograph. Marcus ordered the broadcast stopped, but the camera continued recording long enough to show the attorney pressing a legal document into his hands.
Within minutes, the story was everywhere.
Aura’s executives had publicly announced a manufacturing program they were not legally authorized to begin.
The financial markets reacted sharply when trading resumed, and investors demanded answers. The board ordered an immediate review of the company’s patent disclosures, executive appointments, and statements concerning Vivian’s qualifications.
Marcus called me repeatedly.
I didn’t answer.
By midnight, he was racing toward our former penthouse.
I learned later from the building’s longtime concierge that Marcus entered the lobby looking as though he hadn’t slept in days. He ignored the man’s warning that movers had been there and hurried upstairs.
When he opened the apartment door, he found the rooms almost empty.
The furniture I’d owned was gone.
My paintings were gone.
The cabinets that once held my books stood bare.
His clothes remained neatly arranged in the bedroom, but my side of the closet was empty.
On the entry table sat my key.
He called again.
My phone was switched off.
The next morning, my attorney received a message from Aura demanding that I return immediately to the company and restore the licenses. Their letter suggested that my resignation had been an emotional reaction to an ordinary management decision.
Our attorney replied with copies of the relevant agreements, the termination notices, and documentation showing the disputed formulations had been registered through my company before Aura was incorporated.
The legal process would take time, but the essential issue was clear.
Marcus had built his manufacturing plans around technology he didn’t own outright.
He’d simply assumed I would never withdraw permission.
Two weeks later, I heard that Aura’s research division was struggling.
Their chemists had tried to reconstruct our flagship formula from the pages in Vivian’s possession, but they couldn’t reproduce its stability. The samples smelled pleasant initially, then changed unpleasantly after several days.
The missing information wasn’t something a person could guess from a list of ingredients.
I’d spent years refining the temperature controls, botanical interactions, and production techniques that made the fragrance reliable.
Marcus had dismissed those details as laboratory housekeeping.
Now his company couldn’t manufacture a product that met its own quality standards.
A former colleague, Dr. Kenneth Choi, called me one evening.
He had worked beside me for four years and sounded exhausted.
“Elena, I don’t know what to say. They’ve got us running experiments around the clock, but we can’t reproduce the stabilization process.”
“I’m sorry you’re going through that.”
“Vivian keeps insisting we should substitute cheaper ingredients. Marcus thinks we can solve everything by throwing money at the problem.”
I closed my eyes.
“Kenneth, you know better than that.”
“I do. That’s why I’m calling to tell you I’m resigning. I should have spoken up when they took your name off the work.”
His apology touched me more than I’d expected.
“You did good work there,” I told him. “Don’t let this ruin your confidence.”
He paused.
“Would you consider working with me again someday?”
I looked around Julian’s new laboratory, with its clean workbenches and shelves of carefully labeled ingredients.
“Send me your résumé.”
For the first time in months, I smiled without forcing it.
